Market Overview:
The global ketogenic diet therapeutics market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of obesity and other lifestyle diseases, rising awareness about the benefits of ketogenic diets, and technological advancements in the field of ketogenic diet therapeutics. The global ketogenic diet therapeutics market can be segmented on the basis of type into ketogenic supplements, ketogenic milk powder,ketogenic meals, andketo snacks. The weight loss crowd is expected to account forthe majority shareof the globalketo supplementmarket duringthe forecast period. However, there is an increasing demand for therapeutic foods such as Ketocal®in epilepsy patients owingto theirnutritional benefitsand palatability.
Product Definition:
A ketogenic diet is a very low-carbohydrate, high-fat diet that causes the body to use fat rather than glucose for energy. It's been used to treat epilepsy since the 1920s.
Ketogenic Supplements:
Ketogenic supplements are nutritional products that help in establishing and maintaining the state of ketosis in the body. Ketosis is a natural metabolic process, which takes place when glucose levels in the body decrease to less than 5% of total blood sugar.
Ketogenic Milk Powder:
Ketogenic milk powder is a keto-friendly alternative to dairy products like milk, cream cheese, and others. It has been proven to be an effective substitute for high carb foods in the diet. Ketogenic powders are usually made from MCT oil or coconut oil and hence it contains medium chain triglycerides (MCT). These ingredients offer several health benefits including weight loss, improved brain function along with better energy level among others.
Application Insights:
Epilepsy patients held the largest share of the ketogenic diet therapeutics market in 2017. This is due to growing incidence of epilepsy and rising awareness about its treatment. For instance, according to a study published in January 2018 in Epilepsy & Behavior, ketogenic diets are being used for treating epilepsy because it reduces seizure frequency more than medication does. Furthermore, new research studies are supporting this application segment; for instance, a recent study found that obese people suffering from epilepsy should be treated with the keto diet rather than standard calorie restricted diets. However Ketone salts are not yet approved by FDA for use in epilepsy and there's still much research into this application area.
Other applications include weight loss crowd and other medical conditions (such as Parkinson¢â‚¬â„¢s disease).
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period. This can be attributed to rising awareness about nutritional products, increasing prevalence of obesity and diabetes, and availability of a wide variety of ketogenic foods in this region. Asia Pacific is anticipated to witness lucrative growth over the coming years owing to growing consumer awareness regarding health issues such as obesity, type 2 diabetes, heart diseases & stroke along with epilepsy disorder among others.
The key players operating in this space are Hain Celestial Group Inc.; JBF Corporation; Abbott; Tyson Foods Inc.; Cargill Inc.; National Dairy Products Corp., Anheuser-Busch Companies LLC; Danone S.A.; Kellogg’s Co.
Growth Factors:
- Increasing awareness about the benefits of ketogenic diet for weight loss and other health conditions is driving the growth of ketogenic diet therapeutics market.
- Rising prevalence of obesity, diabetes, and other lifestyle diseases is fueling the demand for ketogenic diet therapeutics.
- Growing popularity of low-carbohydrate and high-fat diets is propelling the growth of ketogenic diet therapeutics market.
- increasing research on therapeutic potentials of ketogenic diets is providing a boost to this market segment
Scope Of The Report
Report Attributes
Report Details
Report Title
Ketogenic Diet Therapeutics Market Research Report
By Type
Ketogenic Supplements, Ketogenic Milk Powder, Ketogenic Meals, Ketogenic Snacks
By Application
Epilepsy Patients, Weight Loss Crowd, Other
By Companies
Nestle, Danone, Abbott Nutrition, Ancient Nutrition, Zenwise Health, Ample Foods, Pruvit Ventures, Bulletproof 360, Ajinomoto, Love Good Fats, Guangzhou Jintong, OnKeto, Shenzhen Zeneca Bio-Technology, Quest Nutrition, Altas Bar, Natures Plus, Perfect Keto, Solace Nutrition
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
191
Number of Tables & Figures
134
Customization Available
Yes, the report can be customized as per your need.
Global Ketogenic Diet Therapeutics Market Report Segments:
The global Ketogenic Diet Therapeutics market is segmented on the basis of:
Types
Ketogenic Supplements, Ketogenic Milk Powder, Ketogenic Meals, Ketogenic Snacks
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Epilepsy Patients, Weight Loss Crowd, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Nestle
- Danone
- Abbott Nutrition
- Ancient Nutrition
- Zenwise Health
- Ample Foods
- Pruvit Ventures
- Bulletproof 360
- Ajinomoto
- Love Good Fats
- Guangzhou Jintong
- OnKeto
- Shenzhen Zeneca Bio-Technology
- Quest Nutrition
- Altas Bar
- Natures Plus
- Perfect Keto
- Solace Nutrition
Highlights of The Ketogenic Diet Therapeutics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Ketogenic Supplements
- Ketogenic Milk Powder
- Ketogenic Meals
- Ketogenic Snacks
- By Application:
- Epilepsy Patients
- Weight Loss Crowd
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Ketogenic Diet Therapeutics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A ketogenic diet is a type of diet that helps the body to burn fat for energy. It is also known as the u201cketou201d or u201cketogenicu201d diet. The ketogenic diet is a high-fat, low-carbohydrate eating plan that was first developed in the 1920s to help people with epilepsy control their seizures.
Some of the key players operating in the ketogenic diet therapeutics market are Nestle, Danone, Abbott Nutrition, Ancient Nutrition, Zenwise Health, Ample Foods, Pruvit Ventures, Bulletproof 360, Ajinomoto, Love Good Fats, Guangzhou Jintong, OnKeto, Shenzhen Zeneca Bio-Technology, Quest Nutrition, Altas Bar, Natures Plus, Perfect Keto, Solace Nutrition.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Ketogenic Diet Therapeutics Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Ketogenic Diet Therapeutics Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Ketogenic Diet Therapeutics Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Ketogenic Diet Therapeutics Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Ketogenic Diet Therapeutics Market Size & Forecast, 2018-2028
4.5.1 Ketogenic Diet Therapeutics Market Size and Y-o-Y Growth
4.5.2 Ketogenic Diet Therapeutics Market Absolute $ Opportunity
Chapter 5 Global Ketogenic Diet Therapeutics Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Ketogenic Diet Therapeutics Market Size Forecast by Type
5.2.1 Ketogenic Supplements
5.2.2 Ketogenic Milk Powder
5.2.3 Ketogenic Meals
5.2.4 Ketogenic Snacks
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Ketogenic Diet Therapeutics Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Ketogenic Diet Therapeutics Market Size Forecast by Applications
6.2.1 Epilepsy Patients
6.2.2 Weight Loss Crowd
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Ketogenic Diet Therapeutics Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Ketogenic Diet Therapeutics Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Ketogenic Diet Therapeutics Analysis and Forecast
9.1 Introduction
9.2 North America Ketogenic Diet Therapeutics Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Ketogenic Diet Therapeutics Market Size Forecast by Type
9.6.1 Ketogenic Supplements
9.6.2 Ketogenic Milk Powder
9.6.3 Ketogenic Meals
9.6.4 Ketogenic Snacks
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Ketogenic Diet Therapeutics Market Size Forecast by Applications
9.10.1 Epilepsy Patients
9.10.2 Weight Loss Crowd
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Ketogenic Diet Therapeutics Analysis and Forecast
10.1 Introduction
10.2 Europe Ketogenic Diet Therapeutics Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Ketogenic Diet Therapeutics Market Size Forecast by Type
10.6.1 Ketogenic Supplements
10.6.2 Ketogenic Milk Powder
10.6.3 Ketogenic Meals
10.6.4 Ketogenic Snacks
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Ketogenic Diet Therapeutics Market Size Forecast by Applications
10.10.1 Epilepsy Patients
10.10.2 Weight Loss Crowd
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Ketogenic Diet Therapeutics Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Ketogenic Diet Therapeutics Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Ketogenic Diet Therapeutics Market Size Forecast by Type
11.6.1 Ketogenic Supplements
11.6.2 Ketogenic Milk Powder
11.6.3 Ketogenic Meals
11.6.4 Ketogenic Snacks
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Ketogenic Diet Therapeutics Market Size Forecast by Applications
11.10.1 Epilepsy Patients
11.10.2 Weight Loss Crowd
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Ketogenic Diet Therapeutics Analysis and Forecast
12.1 Introduction
12.2 Latin America Ketogenic Diet Therapeutics Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Ketogenic Diet Therapeutics Market Size Forecast by Type
12.6.1 Ketogenic Supplements
12.6.2 Ketogenic Milk Powder
12.6.3 Ketogenic Meals
12.6.4 Ketogenic Snacks
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Ketogenic Diet Therapeutics Market Size Forecast by Applications
12.10.1 Epilepsy Patients
12.10.2 Weight Loss Crowd
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Ketogenic Diet Therapeutics Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Ketogenic Diet Therapeutics Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Ketogenic Diet Therapeutics Market Size Forecast by Type
13.6.1 Ketogenic Supplements
13.6.2 Ketogenic Milk Powder
13.6.3 Ketogenic Meals
13.6.4 Ketogenic Snacks
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Ketogenic Diet Therapeutics Market Size Forecast by Applications
13.10.1 Epilepsy Patients
13.10.2 Weight Loss Crowd
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Ketogenic Diet Therapeutics Market: Competitive Dashboard
14.2 Global Ketogenic Diet Therapeutics Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Nestle
14.3.2 Danone
14.3.3 Abbott Nutrition
14.3.4 Ancient Nutrition
14.3.5 Zenwise Health
14.3.6 Ample Foods
14.3.7 Pruvit Ventures
14.3.8 Bulletproof 360
14.3.9 Ajinomoto
14.3.10 Love Good Fats
14.3.11 Guangzhou Jintong
14.3.12 OnKeto
14.3.13 Shenzhen Zeneca Bio-Technology
14.3.14 Quest Nutrition
14.3.15 Altas Bar
14.3.16 Natures Plus
14.3.17 Perfect Keto
14.3.18 Solace Nutrition
